These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

CorMedix's DefenCath cuts infection risk by 71% for dialysis patients. Despite its potential, CMD stock is fairly priced post ...

From Phil King’s Regal Partners to Russel Pillemer’s Pengana Capital, fund managers loved vision treatment hopeful Opthea.

Portage Biotech have more than doubled in the after-hours market after the company reported preclinical results for PORT-7 in a murine mesothelioma model. In the Thursday late trading session, the ...

Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...

Sumeet Bagadia recommended buying these seven breakout shares to buy today - Aavas Financiers, Windlas Biotech, HEG, A B ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Shares of Agenus (AGEN) have been struggling lately and have lost 7.9% over the past week. However, a hammer chart pattern ...